HTL‘s biopolymers are used by pharmaceutical companies and medical device manufacturers worldwide to improve patient care in several therapeutic areas such as ophthalmology, rheumatology and medical aesthetics.

Based in Javené (Ille-et-Vilaine) where its production and R&D activities are located, as well as nearly 200 employees, HTL is expanding internationally and exports 75% of its production.

In 2021, HTL inaugurated a new production unit, the result of an investment of more than 50 million euros, which has enabled it to double its production capacity.

HTL is a pioneer in innovation in its sector and develops innovative applications for biopolymers in cutting-edge medical fields such as regenerative medicine, bioprinting or drug delivery in collaboration with world-renowned research institutes, pharmaceutical companies or start-ups through its incubator.

HTL has created 48 jobs in the last 2 years and plans to create 42 jobs in 2022.


Source : HTL